(Q44304792)

English

Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin Study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

0 references

revascularization

1 reference

based on heuristic

inferred from title

A Michael Lincoff

13

object named as

A Michael Lincoff

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Deepak L. Bhatt

1

object named as

Deepak L Bhatt

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Jeffrey W Moses

10

object named as

Jeffrey W Moses

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Benjamin I Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Peter J Casterella

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Mark Pulsipher

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Matthew Rogers

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Marc Cohen

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Victor E Corrigan

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Thomas J Ryan

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Jeffrey A Breall

9

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Gregory M Eaton

11

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Mitchel A Sklar

12

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Coronary Revascularization Using Integrilin and Single bolus Enoxaparin Study

14

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

0 references

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

20-25

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902631-1

7 January 2021

based on heuristic

inferred from DOI database lookup

TIMI 11B. Enoxaparin versus unfractionated heparin for unstable angina or non-Q-wave myocardial infarction: a double-blind, placebo-controlled, parallel-group, multicenter trial. Rationale, study design, and methods. Thrombolysis in Myocardial Infar

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902631-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular-weight heparins

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902631-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular-weight heparins

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902631-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Even

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902631-1

7 January 2021

based on heuristic

inferred from DOI database lookup

International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events i

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902631-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902631-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902631-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902631-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902631-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902631-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902631-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902631-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902631-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902631-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902631-1

7 January 2021

based on heuristic

inferred from DOI database lookup

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902631-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902631-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902631-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902631-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0735-1097(02)02631-1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44304792&oldid=2109311205"